Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules, 89943-89946 [2016-29771]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
compliance with those requirements
will be one element of a broader
qualitative and quantitative assessment
of capital adequacy.11
Noncomplex SLHCs under $1 billion
will be assigned an abbreviated version
of the RFI rating system consistent with
the Board’s practice for BHCs outlined
in SR 13–21.12 An offsite review of the
SLHC will be conducted upon receipt of
the lead depository institution’s report
of examination. The supervisory cycle
will be determined by the examination
frequency of the lead depository
institution and the SLHC will be
assigned only a risk management rating
and a composite rating.
Finally, elements of the RFI rating
system that are codified in the Board’s
Bank Holding Company Supervision
Manual 13 and a policy letter issued by
the staff of the Board’s Division of
Banking Supervision and Regulation
will be revised if the proposal to fully
apply the RFI system to certain SLHCs
is finalized.14
Assessment of Capital Adequacy for
SLHCs That Receive Indicative Ratings
For SLHCs that would continue to
receive an indicative rating under the
RFI rating system, the Board proposes
that examiners, in the evaluation of
capital adequacy of an SLHC, consider
the risks inherent in the SLHC’s
activities and the ability of capital to
absorb unanticipated losses, provide a
base for growth, and support the level
and composition of the parent company
and subsidiaries’ debt.
pmangrum on DSK3GDR082PROD with NOTICES
Supervisory Guidance for SLHCs With
Less Than $10 Billion in Assets
In 2013, Board staff published several
supervisory letters extending the use of
the RFI rating system for and
assignment of indicative ratings to
SLHCs and extending the scope and
frequency requirements for supervised
holding companies with total
11 See Sections 4060 and 4061 of the Bank
Holding Company Supervision Manual;
Supervision and Regulation Letter 15–19 (December
18, 2015), available at https://
www.federalreserve.gov/bankinforeg/srletters/
sr1519.htm; Supervision and Regulation Letter 15–
6 (April 6, 2015), available at https://
www.federalreserve.gov/bankinforeg/srletters/
sr1506.htm; Supervision and Regulation Letter 09–
04 (February 24, 2009, revised December 21, 2015),
available at https://www.federalreserve.gov/
boarddocs/srletters/2009/sr0904.htm.
12 Supervision and Regulation Letter 13–21
(December 17, 2013), available at https://
www.federalreserve.gov/bankinforeg/srletters/
sr1321.htm.
13 Available at https://www.federalreserve.gov/
boarddocs/supmanual/supervision_bhc.htm.
14 See Supervision and Regulation Letter 04–18
(December 6, 2014), available at https://
www.federalreserve.gov/boarddocs/srletters/2004/
sr0418.htm.
VerDate Sep<11>2014
15:08 Dec 12, 2016
Jkt 241001
consolidated assets of $10 billion or less
to SLHCs. Until such time as the Board
adopts a final rule on the application of
the RFI rating system to SLHCs, SLHCs
may refer to these letters for staff-level
guidance on the use of indicative
ratings.
The Board invites comment on all
aspects of this proposal.
III. Regulatory Analysis
Paperwork Reduction Act
There is no collection of information
required by this proposal that would be
subject to the Paperwork Reduction Act
of 1995, 44 U.S.C. 3501 et seq.
Regulatory Flexibility Analysis
The Regulatory Flexibility Act (RFA)
requires an agency to publish an initial
regulatory flexibility analysis with a
proposed rule or certify that the
proposed rule will not have a significant
economic impact on a substantial
number of small entities. Based on its
analysis, and for the reasons stated
below, the rule would not have a
significant economic impact on a
substantial number of small entities.
Nevertheless, the Board is publishing an
initial regulatory flexibility analysis and
requests public comment on all aspects
of its analysis. The Board will, if
necessary, conduct a final regulatory
flexibility analysis after considering the
comments received during the public
comment period.
1. Statement of the need for, and
objectives of, the proposed rule. The
proposed rule would apply the same
supervisory rating system to SLHCs as
currently applies to bank holding
companies. The RFI rating system is an
effective approach to communicating
supervisory expectations to SLHCs. This
proposal furthers the Board’s goal of
ensuring that holding companies that
control depository institutions are
subject to consistent standards and
supervisory programs.
2. Small entities affected by the
proposed rule. Under regulations issued
by the Small Business Administration, a
small entity includes an SLHC with
total assets of $550 million or less. As
of October 31, 2016, there were
approximately 157 small SLHCs. The
proposed rule will not have a significant
economic impact on the entities that it
affects because the proposal does not
impose any recordkeeping, reporting, or
compliance requirements. The Board
invites comment on the effect of the
proposed rule on small entities.
3. Recordkeeping, reporting, and
compliance requirements. The proposed
rule would not impose any
recordkeeping, reporting, or compliance
requirements.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
89943
4. Other Federal rules. The Board has
not identified any likely duplication,
overlap and/or potential conflict
between the proposed rule and any
Federal rule.
5. Significant alternatives to the
proposed revisions. The Board believes
that this proposal will not have a
significant economic impact on small
banking organizations supervised by the
Board and therefore believes that there
are no significant alternatives to this
proposal that would reduce the
economic impact on small banking
organizations supervised by the Board.
The Board solicits comment on any
significant alternatives that would
reduce the regulatory burden associated
on small entities with this proposed
rule.
Solicitation of Comments on Use of
Plain Language
Section 722 of the Gramm-LeachBliley Act requires the Board to use
plain language in all proposed and final
rules published after January 1, 2000.
The Board invites comment on how to
make this proposed rule easier to
understand. For example:
• Has the Board organized the
material to suit your needs? If not, how
could the proposal be more clearly
stated?
• Are the requirements in the
proposal clearly stated? If not, how
could the proposal be more clearly
stated?
• Does the proposal contain technical
language or jargon that is not clear? If
so, what language requires clarification?
• Would a different format (grouping
and order of sections, use of headings,
paragraphing) make the proposal easier
to understand? If so, what changes
would make the proposal easier to
understand?
• Would more, but shorter, sections
be better? If so, which sections should
be changed?
• What else could the Board do to
make the proposal easier to understand?
By order of the Board of Governors of the
Federal Reserve System, December 8, 2016.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2016–29891 Filed 12–12–16; 8:45 am]
BILLING CODE 6210–01–P
FEDERAL TRADE COMMISSION
Granting of Request for Early
Termination of the Waiting Period
Under the Premerger Notification
Rules
Section 7A of the Clayton Act, 15
U.S.C. 18a, as added by Title II of the
E:\FR\FM\13DEN1.SGM
13DEN1
89944
Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
Hart-Scott-Rodino Antitrust
Improvements Act of 1976, requires
persons contemplating certain mergers
or acquisitions to give the Federal Trade
Commission and the Assistant Attorney
General advance notice and to wait
designated periods before
consummation of such plans. Section
7A(b)(2) of the Act permits the agencies,
in individual cases, to terminate this
waiting period prior to its expiration
and requires that notice of this action be
published in the Federal Register.
The following transactions were
granted early termination—on the dates
indicated—of the waiting period
provided by law and the premerger
notification rules. The listing for each
transaction includes the transaction
number and the parties to the
transaction. The grants were made by
the Federal Trade Commission and the
Assistant Attorney General for the
Antitrust Division of the Department of
Justice. Neither agency intends to take
any action with respect to these
proposed acquisitions during the
applicable waiting period.
EARLY TERMINATIONS GRANTED NOVEMBER 1, 2016 THRU NOVEMBER 30, 2016
11/01/2016
20170004
20170060
20170110
G
G
G
Sofina s.a.; BCP CC Holdings L.P.; Sofina s.a.
Roche Holding Ltd; Hanmi Pharmaceutical Co., Ltd.; Roche Holding Ltd
Wellspring Capital Partners V, L.P.; MM Hoffmaster Holdings L.P.; Wellspring Capital Partners V, L.P.
11/02/2016
20161726
20170008
20170013
20170114
G
G
G
G
Berry Plastics Group, Inc.; AEP Industries Inc.; Berry Plastics Group, Inc.
Tech Data Corporation; Avnet, Inc.; Tech Data Corporation.
B&G Foods, Inc.; The Garfield Weston Charitable Foundation; B&G Foods, Inc.
RHI AG; Magnesita Refratarios S.A.; RHI AG.
11/03/2016
20170104
G
Tenex Capital Partners II, L.P.; Pugh Oil Company, Inc.; Tenex Capital Partners II, L.P.
11/04/2016
20170026
20170027
20170084
20170117
20170118
20170124
20170125
20170126
20170127
20170132
20170135
20170138
20170145
G
G
G
G
G
G
G
G
G
G
G
G
G
Francisco Partners IV, L.P.; Eric and Amy Huang Legacy Trust u/a 9/30/11; Francisco Partners IV, L.P.
Francisco Partners IV, L.P.; Amy B. Huang Legacy Trust u/a 2/1/12; Francisco Partners IV, L.P.
Equistone V FPCI; Wayzata Opportunities Fund II, L.P.; Equistone V FPCI.
Comvest Investment Partners V, L.P.; Lasko Group, Inc.; Comvest Investment Partners V, L.P.
Acrisure Investors FO, LLC; Genstar Capital Partners VI, L.P.; Acrisure Investors FO, LLC.
Onex Partners IV LP; Supervalu Inc.; Onex Partners IV LP.
Wynnchurch Capital Partners IV, L.P.; Rosboro, LLC; Wynnchurch Capital Partners IV, L.P.
Kayne Anderson Energy Fund VI, L.P.; RSP Permian, Inc.; Kayne Anderson Energy Fund VI, L.P.
Kayne Anderson Energy Fund VII, L.P.; RSP Permian, Inc.; Kayne Anderson Energy Fund VII, L.P.
Nationwide Mutual Insurance Company; JNF Investors LLC; Nationwide Mutual Insurance Company.
Carlyle Partners VI Cayman, L.P.; Total S.A.; Carlyle Partners VI Cayman, L.P.
ITOCHU Corporation; Empire Gen Holdings, Inc.; ITOCHU Corporation.
Unibel; White Knight VIII FPCI; Unibel.
11/07/2016
20170035
20170039
20170071
20170115
20170116
20170123
20170147
20170157
G
G
G
G
G
G
G
G
Warburg Pincus Private Equity XII, L.P.; Ascentium Capital LLC; Warburg Pincus Private Equity XII, L.P.
Hanwha General Chemical Co., Ltd.; Hanwha Q Cells Korea Corp.; Hanwha General Chemical Co., Ltd.
Allergan plc; AstraZeneca PLC; Allergan plc.
Verizon Communications Inc.; AT&T Inc.; Verizon Communications Inc.
AT&T Inc.; Verizon Communications Inc.; AT&T Inc.
Novartis AG; Selexys Pharmaceuticals Corporation; Novartis AG.
Hainan Cihang Charitable Foundation; CIT Group Inc.; Hainan Cihang Charitable Foundation.
H.I.G. Middle Market LBO Fund II, L.P.; Mercury Capital, L.P.; H.I.G. Middle Market LBO Fund II, L.P.
11/08/2016
20170085
20170130
20170142
G
G
G
Endeavour Capital Fund VII, L.P.; OFD Holdco, Inc.; Endeavour Capital Fund VII, L.P.
Oaktree Principal Fund VI, L.P.; SunOpta, Inc.; Oaktree Principal Fund VI, L.P.
AEA Investors Fund VI LP; CHS Private Equity V L.P.; AEA Investors Fund VI LP.
11/10/2016
pmangrum on DSK3GDR082PROD with NOTICES
20161294
20170152
G
G
Promotora de Inversiones Mexicanas, S.A.; CEMEX S.A.B. de C.V.; Promotora de Inversiones Mexicanas, S.A.
Platte River Equity III, L.P.; H. J. Baker & Bro., Inc.; Platte River Equity III, LP.
11/14/2016
20170119
20170133
G
G
HKW Capital Partners IV, L.P.; Xirgo Technologies, Inc.; HKW Capital Partners IV, L.P.
j2 Global, Inc.; Everyday Health, Inc.; j2 Global, Inc.
11/15/2016
20160836
VerDate Sep<11>2014
G
Verizon Communications Inc.; Carl C. Icahn; Verizon Communications Inc.
15:08 Dec 12, 2016
Jkt 241001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
E:\FR\FM\13DEN1.SGM
13DEN1
Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
EARLY TERMINATIONS GRANTED NOVEMBER 1, 2016 THRU NOVEMBER 30, 2016—Continued
20170153
20170154
20170158
20170160
20170161
20170168
20170176
20170177
20170183
20170190
20170191
G
G
G
G
G
G
G
G
G
G
G
Mitsubishi Materials Corporation; Nordic Capital V, L.P.; Mitsubishi Materials Corporation.
CONSOL Energy Inc.; Noble Energy, Inc.; CONSOL Energy Inc.
Quad-C Partners VIII, L.P.; Fusion Partners, LLC; Quad-C Partners VIII, L.P.
Buckeye Partners, L.P.; Vitol Investment Partnership Limited; Buckeye Partners, L.P.
Buckeye Partners, L.P.; Vitol Holding B.V.; Buckeye Partners, L.P.
Quantum Energy Partners VI, LP; Freeport-McMoRan Inc.; Quantum Energy Partners VI, LP.
Soohyung Kim; Twin River Worldwide Holdings, Inc.; Soohyung Kim.
InPhi Corporation; ClariPhy Communications, Inc.; InPhi Corporation.
Quad-C Partners VIII, L.P.; Wells Fargo & Company; Quad-C Partners VIII, L.P.
Richard Webb; Kinder Morgan, Inc.; Richard Webb.
Galanos Investments L.P.; KPS Special Situations Fund IV, LP; Galanos Investments L.P.
11/16/2016
20170170
20170196
G
G
Audax Private Equity Fund V-A, L.P.; Silver Oak Services Partners, L.P.; Audax Private Equity Fund V-A, L.P.
PMHC II, Inc.; Eramet, S.A.; PMHC II, Inc.
11/17/2016
20170129
20170164
20170167
20170187
20170188
G
G
G
G
G
Amgen Inc.; Arrowhead Pharmaceuticals, Inc.; Amgen Inc.
Daiichi Sankyo Co., Ltd.; Inspirion Delivery Technologies LLC; Daiichi Sankyo Co., Ltd.
NextEra Energy, Inc.; Energy Future Holdings Corp.; NextEra Energy, Inc.
Thomas A. Garrett; Cerberus Partners, L.P.; Thomas A. Garrett.
Archrock Partners, L.P.; Archrock, Inc.; Archrock Partners, L.P.
11/18/2016
20170097
20170102
20170162
20170163
G
G
G
G
CBOE Holdings, Inc.; Bats Global Markets; CBOE Holdings, Inc.
Joseph Mansueto; PitchBook Data, Inc.; Joseph Mansueto.
Constellation Brands, Inc.; Eugenie Patri Sebastien EPS, SA; Constellation Brands, Inc.
Constellation Brands, Inc.; Jorge Paulo Lemann; Constellation Brands, Inc.
11/21/2016
20161824
20170209
20170215
20170220
20170225
20170229
20170250
G
G
G
G
G
G
G
Blackfriars Corp.; Saudi Basic Industries Corp.; Blackfriars Corp.
Odyssey Investment Partners Fund V, L.P.; HSM Tek, Inc.; Odyssey Investment Partners Fund V, L.P.
SG Growth Partners III, LP; Weston Presidio V, L.P.; SG Growth Partners III, LP.
Enviva Partners, LP; Riverstone/Carlyle Renewable and Alternative Energy Fund II,; Enviva Partners, LP.
Sun Hydraulics Corporation; Frank W. Murphy III; Sun Hydraulics Corporation.
Bain Capital Europe Fund IV, L.P.; ASF Park Acquisition LP; Bain Capital Europe Fund IV, L.P.
Bed Bath & Beyond Inc.; Daniel R. Randolph; Bed Bath & Beyond Inc.
11/22/2016
20170208
G
Nestle S.A.; Aimmune Therapeutics, Inc.; Nestle S.A.
11/23/2016
20170137
20170173
20170174
20170179
20170180
20170181
20170217
G
G
G
G
G
G
G
Henderson Group plc; Janus Capital Group Inc.; Henderson Group plc.
Huntington Ingalls Industries, Inc.; New Mountain Partners III, L.P.; Huntington Ingalls Industries, Inc.
BW NHHC Co-Invest, L.P.; Wellspring Capital Partners V, L.P.; BW NHHC Co-Invest, L.P.
Comcast Corporation; Racecar Holdings, LLC; Comcast Corporation.
Steven E. Grosser; Racecar Holdings, LLC; Steven E. Grosser.
Patrick J. McAdaragh; Racecar Holdings, LLC; Patrick J. McAdaragh.
Synopsys, Inc.; LLR Equity Partners IV, L.P.; Synopsys, Inc.
pmangrum on DSK3GDR082PROD with NOTICES
11/28/2016
20170113
20170136
20170156
20170213
20170218
20170226
20170228
20170234
20170238
20170239
20170241
20170246
20170252
20170260
20170264
20170266
20170268
VerDate Sep<11>2014
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
G
Micro Focus International plc; Hewlett Packard Enterprise Company; Micro Focus International plc.
GTCR Fund XI/A LP; DPC Holdings, LLC; GTCR Fund XI/A LP.
Lintec Corporation; Platinum Equity Capital Evergreen Partners, L.P.; Lintec Corporation.
HollyFrontier Corporation; Suncor Energy Inc.; HollyFrontier Corporation.
SpeedCast International Limited; Harris Corporation; SpeedCast International Limited.
The Kansai Electric Power Co., Inc.; Marubeni Corporation; The Kansai Electric Power Co., Inc.
American Midstream Partners, LP; ArcLight Energy Partners Fund V, L.P.; American Midstream Partners, LP.
Shangtex Holding Co. Ltd.; Dr. Henry Tan; Shangtex Holding Co. Ltd.
JLL Partners Fund VII, L.P.; MedPlast Holdings, Inc.; JLL Partners Fund VII, L.P.
Water Street Healthcare Partners III, L.P.; MedPlast Holdings, Inc.; Water Street Healthcare Partners III, L.P.
Genstar Capital Partners VII, L.P.; David D. Morgan; Genstar Capital Partners VII, L.P.
Blackstone Capital Partners VII L.P.; Team Health Holdings, Inc.; Blackstone Capital Partners VII L.P.
Greencore Group plc; Charlesbank Equity Fund VII, Limited Partnership; Greencore Group plc.
Leviton Manufacturing Co., Inc.; Allan B. Hubbard; Leviton Manufacturing Co., Inc.
NuStar Energy L.P.; Martin Midstream Partners L.P.; NuStar Energy L.P.
AP VIII DSB Holdings, L.P.; Ascension Health Alliance; AP VIII DSB Holdings, L.P.
Kendall Automotive Group, Inc.; Gayle and James Chalfant; Kendall Automotive Group, Inc.
15:08 Dec 12, 2016
Jkt 241001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\13DEN1.SGM
13DEN1
89945
89946
Federal Register / Vol. 81, No. 239 / Tuesday, December 13, 2016 / Notices
EARLY TERMINATIONS GRANTED NOVEMBER 1, 2016 THRU NOVEMBER 30, 2016—Continued
20170269
20170271
20170272
20170280
20170289
G
G
G
G
G
Kendall Automotive Group, Inc.; David and Lorraine Edmark; Kendall Automotive Group, Inc.
Ascent Holdings, LLC; Fulcrum BioEnergy, Inc.; Ascent Holdings, LLC.
JBG SMITH Properties; JBG/Operating Partners, L.P.; JBG SMITH Properties.
Blue Star Parent, L.P.; Ansira Holdings, LLC; Blue Star Parent, L.P.
Antelope NewCo, Inc.; AlixPartners Holdings, LLP; Antelope NewCo, Inc.
11/30/2016
20170159
20170169
20170274
20170279
20170281
20170284
20170296
20170298
20170300
20170306
G
G
G
G
G
G
G
G
G
G
The Hearst Family Trust; GTCR Fund X/A LP; The Hearst Family Trust.
Insight MB Parent LLC; MB Parent Holdings, LLC; Insight MB Parent LLC.
Quintiles IMS Holdings, Inc.; Jon C. Anderson; Quintiles IMS Holdings, Inc.
Calpine Corporation; NAPGS Holdco, LLC; Calpine Corporation.
Adobe Systems Incorporated; TubeMogul, Inc.; Adobe Systems Incorporated.
CENTRO ARTE SCIENZA E TECNOLOGIA S.R.L.; Nestle S. A.; CENTRO ARTE SCIENZA E TECNOLOGIA S.R.L.
Bain Capital Fund XI, L.P.; Blue Nile, Inc.; Bain Capital Fund XI, L.P.
AIPCF VI AIV Moly-Cop (Cayman), LP; Arrium Limited; AIPCF VI AIV Moly-Cop (Cayman), LP.
Wind Point Partners, VIII-A, L.P.; Michael J. Baab; Wind Point Partners, VIII-A, L.P.
AIM Marina Holdings, LLC; John D. Brewer, Jr. and Margaret S. Brewer; AIM Marina Holdings, LLC.
FOR FURTHER INFORMATION CONTACT:
Theresa Kingsberry Program Support
Specialist, Federal Trade Commission
Premerger Notification Office Bureau of
Competition, Room CC–5301,
Washington, DC 20024, (202) 326–3100.
By direction of the Commission.
Donald S. Clark
Secretary.
Electronic Submissions
[FR Doc. 2016–29771 Filed 12–12–16; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–E–0625]
Determination of Regulatory Review
Period for Purposes of Patent
Extension; NUCALA
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) has determined
the regulatory review period for
NUCALA and is publishing this notice
of that determination as required by
law. FDA has made the determination
because of the submission of an
application to the Director of the U.S.
Patent and Trademark Office (USPTO),
Department of Commerce, for the
extension of a patent which claims that
human biological product.
DATES: Anyone with knowledge that any
of the dates as published (see the
SUPPLEMENTARY INFORMATION section) are
incorrect may submit either electronic
or written comments and ask for a
redetermination by February 13, 2017.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
pmangrum on DSK3GDR082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:08 Dec 12, 2016
Jkt 241001
extension acted with due diligence
during the regulatory review period by
June 12, 2017. See ‘‘Petitions’’ in the
SUPPLEMENTARY INFORMATION section for
more information.
ADDRESSES: You may submit comments
as follows:
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2016–E–0625 for ‘‘Determination of
Regulatory Review Period for Purposes
of Patent Extension; NUCALA.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Division of Dockets
Management. If you do not wish your
name and contact information to be
made publicly available, you can
provide this information on the cover
sheet and not in the body of your
comments and you must identify this
information as ‘‘confidential.’’ Any
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 81, Number 239 (Tuesday, December 13, 2016)]
[Notices]
[Pages 89943-89946]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29771]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
Granting of Request for Early Termination of the Waiting Period
Under the Premerger Notification Rules
Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II
of the
[[Page 89944]]
Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires persons
contemplating certain mergers or acquisitions to give the Federal Trade
Commission and the Assistant Attorney General advance notice and to
wait designated periods before consummation of such plans. Section
7A(b)(2) of the Act permits the agencies, in individual cases, to
terminate this waiting period prior to its expiration and requires that
notice of this action be published in the Federal Register.
The following transactions were granted early termination--on the
dates indicated--of the waiting period provided by law and the
premerger notification rules. The listing for each transaction includes
the transaction number and the parties to the transaction. The grants
were made by the Federal Trade Commission and the Assistant Attorney
General for the Antitrust Division of the Department of Justice.
Neither agency intends to take any action with respect to these
proposed acquisitions during the applicable waiting period.
Early Terminations Granted November 1, 2016 Thru November 30, 2016
------------------------------------------------------------------------
------------------------------------------------------------------------
11/01/2016
------------------------------------------------------------------------
20170004.................. G Sofina s.a.; BCP CC Holdings
L.P.; Sofina s.a.
20170060.................. G Roche Holding Ltd; Hanmi
Pharmaceutical Co., Ltd.;
Roche Holding Ltd
20170110.................. G Wellspring Capital Partners
V, L.P.; MM Hoffmaster
Holdings L.P.; Wellspring
Capital Partners V, L.P.
------------------------------------------------------------------------
11/02/2016
------------------------------------------------------------------------
20161726.................. G Berry Plastics Group, Inc.;
AEP Industries Inc.; Berry
Plastics Group, Inc.
20170008.................. G Tech Data Corporation; Avnet,
Inc.; Tech Data Corporation.
20170013.................. G B&G Foods, Inc.; The Garfield
Weston Charitable
Foundation; B&G Foods, Inc.
20170114.................. G RHI AG; Magnesita Refratarios
S.A.; RHI AG.
------------------------------------------------------------------------
11/03/2016
------------------------------------------------------------------------
20170104.................. G Tenex Capital Partners II,
L.P.; Pugh Oil Company,
Inc.; Tenex Capital Partners
II, L.P.
------------------------------------------------------------------------
11/04/2016
------------------------------------------------------------------------
20170026.................. G Francisco Partners IV, L.P.;
Eric and Amy Huang Legacy
Trust u/a 9/30/11; Francisco
Partners IV, L.P.
20170027.................. G Francisco Partners IV, L.P.;
Amy B. Huang Legacy Trust u/
a 2/1/12; Francisco Partners
IV, L.P.
20170084.................. G Equistone V FPCI; Wayzata
Opportunities Fund II, L.P.;
Equistone V FPCI.
20170117.................. G Comvest Investment Partners
V, L.P.; Lasko Group, Inc.;
Comvest Investment Partners
V, L.P.
20170118.................. G Acrisure Investors FO, LLC;
Genstar Capital Partners VI,
L.P.; Acrisure Investors FO,
LLC.
20170124.................. G Onex Partners IV LP;
Supervalu Inc.; Onex
Partners IV LP.
20170125.................. G Wynnchurch Capital Partners
IV, L.P.; Rosboro, LLC;
Wynnchurch Capital Partners
IV, L.P.
20170126.................. G Kayne Anderson Energy Fund
VI, L.P.; RSP Permian, Inc.;
Kayne Anderson Energy Fund
VI, L.P.
20170127.................. G Kayne Anderson Energy Fund
VII, L.P.; RSP Permian,
Inc.; Kayne Anderson Energy
Fund VII, L.P.
20170132.................. G Nationwide Mutual Insurance
Company; JNF Investors LLC;
Nationwide Mutual Insurance
Company.
20170135.................. G Carlyle Partners VI Cayman,
L.P.; Total S.A.; Carlyle
Partners VI Cayman, L.P.
20170138.................. G ITOCHU Corporation; Empire
Gen Holdings, Inc.; ITOCHU
Corporation.
20170145.................. G Unibel; White Knight VIII
FPCI; Unibel.
------------------------------------------------------------------------
11/07/2016
------------------------------------------------------------------------
20170035.................. G Warburg Pincus Private Equity
XII, L.P.; Ascentium Capital
LLC; Warburg Pincus Private
Equity XII, L.P.
20170039.................. G Hanwha General Chemical Co.,
Ltd.; Hanwha Q Cells Korea
Corp.; Hanwha General
Chemical Co., Ltd.
20170071.................. G Allergan plc; AstraZeneca
PLC; Allergan plc.
20170115.................. G Verizon Communications Inc.;
AT&T Inc.; Verizon
Communications Inc.
20170116.................. G AT&T Inc.; Verizon
Communications Inc.; AT&T
Inc.
20170123.................. G Novartis AG; Selexys
Pharmaceuticals Corporation;
Novartis AG.
20170147.................. G Hainan Cihang Charitable
Foundation; CIT Group Inc.;
Hainan Cihang Charitable
Foundation.
20170157.................. G H.I.G. Middle Market LBO Fund
II, L.P.; Mercury Capital,
L.P.; H.I.G. Middle Market
LBO Fund II, L.P.
------------------------------------------------------------------------
11/08/2016
------------------------------------------------------------------------
20170085.................. G Endeavour Capital Fund VII,
L.P.; OFD Holdco, Inc.;
Endeavour Capital Fund VII,
L.P.
20170130.................. G Oaktree Principal Fund VI,
L.P.; SunOpta, Inc.; Oaktree
Principal Fund VI, L.P.
20170142.................. G AEA Investors Fund VI LP; CHS
Private Equity V L.P.; AEA
Investors Fund VI LP.
------------------------------------------------------------------------
11/10/2016
------------------------------------------------------------------------
20161294.................. G Promotora de Inversiones
Mexicanas, S.A.; CEMEX
S.A.B. de C.V.; Promotora de
Inversiones Mexicanas, S.A.
20170152.................. G Platte River Equity III,
L.P.; H. J. Baker & Bro.,
Inc.; Platte River Equity
III, LP.
------------------------------------------------------------------------
11/14/2016
------------------------------------------------------------------------
20170119.................. G HKW Capital Partners IV,
L.P.; Xirgo Technologies,
Inc.; HKW Capital Partners
IV, L.P.
20170133.................. G j2 Global, Inc.; Everyday
Health, Inc.; j2 Global,
Inc.
------------------------------------------------------------------------
11/15/2016
------------------------------------------------------------------------
20160836.................. G Verizon Communications Inc.;
Carl C. Icahn; Verizon
Communications Inc.
[[Page 89945]]
20170153.................. G Mitsubishi Materials
Corporation; Nordic Capital
V, L.P.; Mitsubishi
Materials Corporation.
20170154.................. G CONSOL Energy Inc.; Noble
Energy, Inc.; CONSOL Energy
Inc.
20170158.................. G Quad-C Partners VIII, L.P.;
Fusion Partners, LLC; Quad-C
Partners VIII, L.P.
20170160.................. G Buckeye Partners, L.P.; Vitol
Investment Partnership
Limited; Buckeye Partners,
L.P.
20170161.................. G Buckeye Partners, L.P.; Vitol
Holding B.V.; Buckeye
Partners, L.P.
20170168.................. G Quantum Energy Partners VI,
LP; Freeport-McMoRan Inc.;
Quantum Energy Partners VI,
LP.
20170176.................. G Soohyung Kim; Twin River
Worldwide Holdings, Inc.;
Soohyung Kim.
20170177.................. G InPhi Corporation; ClariPhy
Communications, Inc.; InPhi
Corporation.
20170183.................. G Quad-C Partners VIII, L.P.;
Wells Fargo & Company; Quad-
C Partners VIII, L.P.
20170190.................. G Richard Webb; Kinder Morgan,
Inc.; Richard Webb.
20170191.................. G Galanos Investments L.P.; KPS
Special Situations Fund IV,
LP; Galanos Investments L.P.
------------------------------------------------------------------------
11/16/2016
------------------------------------------------------------------------
20170170.................. G Audax Private Equity Fund V-
A, L.P.; Silver Oak Services
Partners, L.P.; Audax
Private Equity Fund V-A,
L.P.
20170196.................. G PMHC II, Inc.; Eramet, S.A.;
PMHC II, Inc.
------------------------------------------------------------------------
11/17/2016
------------------------------------------------------------------------
20170129.................. G Amgen Inc.; Arrowhead
Pharmaceuticals, Inc.; Amgen
Inc.
20170164.................. G Daiichi Sankyo Co., Ltd.;
Inspirion Delivery
Technologies LLC; Daiichi
Sankyo Co., Ltd.
20170167.................. G NextEra Energy, Inc.; Energy
Future Holdings Corp.;
NextEra Energy, Inc.
20170187.................. G Thomas A. Garrett; Cerberus
Partners, L.P.; Thomas A.
Garrett.
20170188.................. G Archrock Partners, L.P.;
Archrock, Inc.; Archrock
Partners, L.P.
------------------------------------------------------------------------
11/18/2016
------------------------------------------------------------------------
20170097.................. G CBOE Holdings, Inc.; Bats
Global Markets; CBOE
Holdings, Inc.
20170102.................. G Joseph Mansueto; PitchBook
Data, Inc.; Joseph Mansueto.
20170162.................. G Constellation Brands, Inc.;
Eugenie Patri Sebastien EPS,
SA; Constellation Brands,
Inc.
20170163.................. G Constellation Brands, Inc.;
Jorge Paulo Lemann;
Constellation Brands, Inc.
------------------------------------------------------------------------
11/21/2016
------------------------------------------------------------------------
20161824.................. G Blackfriars Corp.; Saudi
Basic Industries Corp.;
Blackfriars Corp.
20170209.................. G Odyssey Investment Partners
Fund V, L.P.; HSM Tek, Inc.;
Odyssey Investment Partners
Fund V, L.P.
20170215.................. G SG Growth Partners III, LP;
Weston Presidio V, L.P.; SG
Growth Partners III, LP.
20170220.................. G Enviva Partners, LP;
Riverstone/Carlyle Renewable
and Alternative Energy Fund
II,; Enviva Partners, LP.
20170225.................. G Sun Hydraulics Corporation;
Frank W. Murphy III; Sun
Hydraulics Corporation.
20170229.................. G Bain Capital Europe Fund IV,
L.P.; ASF Park Acquisition
LP; Bain Capital Europe Fund
IV, L.P.
20170250.................. G Bed Bath & Beyond Inc.;
Daniel R. Randolph; Bed Bath
& Beyond Inc.
------------------------------------------------------------------------
11/22/2016
------------------------------------------------------------------------
20170208.................. G Nestle S.A.; Aimmune
Therapeutics, Inc.; Nestle
S.A.
------------------------------------------------------------------------
11/23/2016
------------------------------------------------------------------------
20170137.................. G Henderson Group plc; Janus
Capital Group Inc.;
Henderson Group plc.
20170173.................. G Huntington Ingalls
Industries, Inc.; New
Mountain Partners III, L.P.;
Huntington Ingalls
Industries, Inc.
20170174.................. G BW NHHC Co-Invest, L.P.;
Wellspring Capital Partners
V, L.P.; BW NHHC Co-Invest,
L.P.
20170179.................. G Comcast Corporation; Racecar
Holdings, LLC; Comcast
Corporation.
20170180.................. G Steven E. Grosser; Racecar
Holdings, LLC; Steven E.
Grosser.
20170181.................. G Patrick J. McAdaragh; Racecar
Holdings, LLC; Patrick J.
McAdaragh.
20170217.................. G Synopsys, Inc.; LLR Equity
Partners IV, L.P.; Synopsys,
Inc.
------------------------------------------------------------------------
11/28/2016
------------------------------------------------------------------------
20170113.................. G Micro Focus International
plc; Hewlett Packard
Enterprise Company; Micro
Focus International plc.
20170136.................. G GTCR Fund XI/A LP; DPC
Holdings, LLC; GTCR Fund XI/
A LP.
20170156.................. G Lintec Corporation; Platinum
Equity Capital Evergreen
Partners, L.P.; Lintec
Corporation.
20170213.................. G HollyFrontier Corporation;
Suncor Energy Inc.;
HollyFrontier Corporation.
20170218.................. G SpeedCast International
Limited; Harris Corporation;
SpeedCast International
Limited.
20170226.................. G The Kansai Electric Power
Co., Inc.; Marubeni
Corporation; The Kansai
Electric Power Co., Inc.
20170228.................. G American Midstream Partners,
LP; ArcLight Energy Partners
Fund V, L.P.; American
Midstream Partners, LP.
20170234.................. G Shangtex Holding Co. Ltd.;
Dr. Henry Tan; Shangtex
Holding Co. Ltd.
20170238.................. G JLL Partners Fund VII, L.P.;
MedPlast Holdings, Inc.; JLL
Partners Fund VII, L.P.
20170239.................. G Water Street Healthcare
Partners III, L.P.; MedPlast
Holdings, Inc.; Water Street
Healthcare Partners III,
L.P.
20170241.................. G Genstar Capital Partners VII,
L.P.; David D. Morgan;
Genstar Capital Partners
VII, L.P.
20170246.................. G Blackstone Capital Partners
VII L.P.; Team Health
Holdings, Inc.; Blackstone
Capital Partners VII L.P.
20170252.................. G Greencore Group plc;
Charlesbank Equity Fund VII,
Limited Partnership;
Greencore Group plc.
20170260.................. G Leviton Manufacturing Co.,
Inc.; Allan B. Hubbard;
Leviton Manufacturing Co.,
Inc.
20170264.................. G NuStar Energy L.P.; Martin
Midstream Partners L.P.;
NuStar Energy L.P.
20170266.................. G AP VIII DSB Holdings, L.P.;
Ascension Health Alliance;
AP VIII DSB Holdings, L.P.
20170268.................. G Kendall Automotive Group,
Inc.; Gayle and James
Chalfant; Kendall Automotive
Group, Inc.
[[Page 89946]]
20170269.................. G Kendall Automotive Group,
Inc.; David and Lorraine
Edmark; Kendall Automotive
Group, Inc.
20170271.................. G Ascent Holdings, LLC; Fulcrum
BioEnergy, Inc.; Ascent
Holdings, LLC.
20170272.................. G JBG SMITH Properties; JBG/
Operating Partners, L.P.;
JBG SMITH Properties.
20170280.................. G Blue Star Parent, L.P.;
Ansira Holdings, LLC; Blue
Star Parent, L.P.
20170289.................. G Antelope NewCo, Inc.;
AlixPartners Holdings, LLP;
Antelope NewCo, Inc.
------------------------------------------------------------------------
11/30/2016
------------------------------------------------------------------------
20170159.................. G The Hearst Family Trust; GTCR
Fund X/A LP; The Hearst
Family Trust.
20170169.................. G Insight MB Parent LLC; MB
Parent Holdings, LLC;
Insight MB Parent LLC.
20170274.................. G Quintiles IMS Holdings, Inc.;
Jon C. Anderson; Quintiles
IMS Holdings, Inc.
20170279.................. G Calpine Corporation; NAPGS
Holdco, LLC; Calpine
Corporation.
20170281.................. G Adobe Systems Incorporated;
TubeMogul, Inc.; Adobe
Systems Incorporated.
20170284.................. G CENTRO ARTE SCIENZA E
TECNOLOGIA S.R.L.; Nestle S.
A.; CENTRO ARTE SCIENZA E
TECNOLOGIA S.R.L.
20170296.................. G Bain Capital Fund XI, L.P.;
Blue Nile, Inc.; Bain
Capital Fund XI, L.P.
20170298.................. G AIPCF VI AIV Moly-Cop
(Cayman), LP; Arrium
Limited; AIPCF VI AIV Moly-
Cop (Cayman), LP.
20170300.................. G Wind Point Partners, VIII-A,
L.P.; Michael J. Baab; Wind
Point Partners, VIII-A, L.P.
20170306.................. G AIM Marina Holdings, LLC;
John D. Brewer, Jr. and
Margaret S. Brewer; AIM
Marina Holdings, LLC.
------------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry Program Support
Specialist, Federal Trade Commission Premerger Notification Office
Bureau of Competition, Room CC-5301, Washington, DC 20024, (202) 326-
3100.
By direction of the Commission.
Donald S. Clark
Secretary.
[FR Doc. 2016-29771 Filed 12-12-16; 8:45 am]
BILLING CODE 6750-01-P
